» Articles » PMID: 31712735

Early Symptoms and Sensations As Predictors of Lung Cancer: a Machine Learning Multivariate Model

Overview
Journal Sci Rep
Specialty Science
Date 2019 Nov 13
PMID 31712735
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to identify a combination of early predictive symptoms/sensations attributable to primary lung cancer (LC). An interactive e-questionnaire comprised of pre-diagnostic descriptors of first symptoms/sensations was administered to patients referred for suspected LC. Respondents were included in the present analysis only if they later received a primary LC diagnosis or had no cancer; and inclusion of each descriptor required ≥4 observations. Fully-completed data from 506/670 individuals later diagnosed with primary LC (n = 311) or no cancer (n = 195) were modelled with orthogonal projections to latent structures (OPLS). After analysing 145/285 descriptors, meeting inclusion criteria, through randomised seven-fold cross-validation (six-fold training set: n = 433; test set: n = 73), 63 provided best LC prediction. The most-significant LC-positive descriptors included a cough that varied over the day, back pain/aches/discomfort, early satiety, appetite loss, and having less strength. Upon combining the descriptors with the background variables current smoking, a cold/flu or pneumonia within the past two years, female sex, older age, a history of COPD (positive LC-association); antibiotics within the past two years, and a history of pneumonia (negative LC-association); the resulting 70-variable model had accurate cross-validated test set performance: area under the ROC curve = 0.767 (descriptors only: 0.736/background predictors only: 0.652), sensitivity = 84.8% (73.9/76.1%, respectively), specificity = 55.6% (66.7/51.9%, respectively). In conclusion, accurate prediction of LC was found through 63 early symptoms/sensations and seven background factors. Further research and precision in this model may lead to a tool for referral and LC diagnostic decision-making.

Citing Articles

LncRNA MANCR is downregulated in non-small cell lung cancer and predicts poor survival.

Tao Y, Liu J, Qiu W, Li Y Discov Oncol. 2025; 16(1):40.

PMID: 39806185 PMC: 11730023. DOI: 10.1007/s12672-025-01739-5.


Research Priorities of the Oncology Nursing Society: 2024-2027.

Rosenzweig M, Belcher S, Braithwaite L, Cuaron L, Fischer-Cartlidge E, Lally R Oncol Nurs Forum. 2024; 51(6):502-515.

PMID: 39431689 PMC: 11697697. DOI: 10.1188/24.ONF.502-515.


Multiplex plasma protein assays as a diagnostic tool for lung cancer.

Ahamed M, Forshed J, Levitsky A, Lehtio J, Bajalan A, Pernemalm M Cancer Sci. 2024; 115(10):3439-3454.

PMID: 39080998 PMC: 11447887. DOI: 10.1111/cas.16300.


Machine Learning as a Tool for Early Detection: A Focus on Late-Stage Colorectal Cancer across Socioeconomic Spectrums.

Galadima H, Anson-Dwamena R, Johnson A, Bello G, Adunlin G, Blando J Cancers (Basel). 2024; 16(3).

PMID: 38339293 PMC: 10854986. DOI: 10.3390/cancers16030540.


Exploring the efficacy of artificial neural networks in predicting lung cancer recurrence: a retrospective study based on patient records.

Lorenc A, Romaszko-Wojtowicz A, Jaskiewicz L, Doboszynska A, Bucinski A Transl Lung Cancer Res. 2023; 12(10):2083-2097.

PMID: 38025814 PMC: 10654430. DOI: 10.21037/tlcr-23-350.


References
1.
Hamilton W, Peters T, Round A, Sharp D . What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax. 2005; 60(12):1059-65. PMC: 1747254. DOI: 10.1136/thx.2005.045880. View

2.
Koyi H, Hillerdal G, Branden E . A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits. Lung Cancer. 2002; 36(1):9-14. DOI: 10.1016/s0169-5002(01)00451-2. View

3.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

4.
Spitz M, Hong W, Amos C, Wu X, Schabath M, Dong Q . A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007; 99(9):715-26. DOI: 10.1093/jnci/djk153. View

5.
Okoli G, Kostopoulou O, Delaney B . Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice. PLoS One. 2018; 13(11):e0207686. PMC: 6248994. DOI: 10.1371/journal.pone.0207686. View